Department of Medicine Faculty

Bio

Administrator Info
Name: Admin
Phone: 612-624-9996
Fax: 612-625-4410
Email: idimdivision@umn.edu
Mail: Mayo Memorial Building, MMC 250, 420 Delaware Street S.E., Minneapolis, MN 55455

Summary
Dr. Tai is a faculty member of the University of Minnesota Division of Infectious Diseases and International Medicine, focusing on orthopedic infections. He trained at Mayo Clinic, where he was Assistant Professor of Medicine and Co-Chief fellow. Aside from his primary research, he is also passionate about diagnostic stewardship, quality improvement, diversity, equity, & inclusion. He is working on multicenter collaborations including but not limited to periprosthetic joint infections, spine infections, and diabetic foot infections.

Research Summary

• Periprosthetic joint infections
• Native vertebral osteomyelitis
• Diagnostic stewardship

Teaching Summary

Diagnostic stewardship; DEI

Clinical Summary

• Orthopedic infectious diseases

Bio

Administrator Info
Email: endofixer@umn.edu

Summary
Dr. Nolawit Tesfaye is an Assistant Professor of Medicine in the Division of Diabetes, Endocrinology and Metabolism at the University of Minnesota. She graduated from the University of Minnesota Medical School in 2005 and then from the Internal Medicine residency program at Hennepin County Medical Center in 2008. She returned to the University of Minnesota to complete fellowship training in Endocrinology, Diabetes and Metabolism in 2011.Dr. Tesfaye enjoys all aspects of general endocrinology, with special interest in diabetes and disorders of bone and mineral metabolism. Her research in fellowship focused on hypoglycemia in diabetes mellitus.

Research Summary

Hypoglycemia in diabetes mellitus

Clinical Summary

General endocrinology, diabetes, disorders of bone and mineral metabolism

Bio

Administrator Info
Name: Nephrology
Phone: 612-624-9444
Email: renaldiv@umn.edu
Mail: 717 Delaware Street SE
MMC 1932
Suite 353 Mpls, MN 55414

Summary
Dr. Thakar is an Assistant Professor of Medicine in the Division of Nephrology and Hypertension. She joined faculty in February 2017. Her clinical and research interests include CKD and Glomerular diseases.

Research Summary

• Chronic Kidney Disease
• Glomerular Disease
• ANCA Vasculitis
• IgA Nephropathy
• Lupus Nephritis

Teaching Summary

• Renal Pathophysiology

Bio

Administrator Info
Email: cvheart@umn.edu
Mail: 420 Delaware Street SE
MMC 508 Mayo
8508A (Campus Delivery Code)
Minneapolis, MN 55455

Summary
Dr. Thenappan received his medical training from the Tamil Nadu Dr. MGR Medial University, India. He then completed his residency training in Internal Medicine in 2005 at St. Francis Hospital with University of Illinois, Evanston, IL. Following this, he worked as a research fellow in the Center for Pulmonary Hypertension at the University of Chicago. Subsequently, he completed his fellowship training in Cardiovascular Medicine in 2012 and fellowship training in Advanced Heart failure and Transplant Cardiology in 2013 at the University of Chicago. Dr. Thenappan is a clinical research scholar interested in translational research in pulmonary vascular disease. During his fellowship training, he worked on redefining the epidemiology of pulmonary arterial hypertension in the current era. His current research focus is on developing novel therapies for right ventricular failure secondary to pulmonary vascular disease. Outside work, he enjoys traveling and spending time with his family.Dr. Thenappan has published on pulmonary vascular disease and right ventricular function in high impact journals including Circulation, Circulation Research, Circulation Heart Failure, Journal of American College of Cardiology, Journal of American Medical Association, Journal of Heart and Lung Transplantation, American Journal of Respiratory and Critical Care Medicine, European Respiratory Journal, and Chest. He is a member of the American Heart Association, American Thoracic Society, International Society of Heart and Lung Transplantation, and Pulmonary Vascular Research Institute, and Pulmonary Hypertension Association.

Clinical Summary

• Cardiology
• Pulmonary Hypertension and Right Heart Failure
• Advanced Heart Failure and Cardiac Transplantation
• Mechanical Circulatory Support

Bio

Administrator Info
Name: Colleen Doyle
Email: doyl0050@umn.edu
Mail: 717 Delaware Street SE
Suite 166
MMC 1932
Minneapolis, MN 55414

Summary
Dr. Thomas completed her Ph.D. training in clinical psychology, with an emphasis on behavioral medicine at Louisiana State University. She later completed internship training in Health Psychology at the University of California, San Diego and a post-doctoral research fellowship in tobacco research at the Nicotine Dependence Center and the Department of Psychiatry and Psychology at the Mayo Clinic, College of Medicine. Prior to joining the faculty of the University of Minnesota, she was an Assistant Professor of Preventive Medicine and Public Health at the University of Kansas Medical Center. There she taught Health Promotion and Disease Prevention to first year medical students and served as a preceptor to students in the Master's in Public Health program. Although primarily a behavioral scientist, Dr. Thomas is also a licensed psychologist specializing in the treatment of anxiety disorders. Her primary research interests targets tobacco control efforts among underserved populations including African American, Native American and East African communities. Her current research uses behavioral interventions to decrease smoking among young adult college students using contingency management approaches or "Quit and Win" smoking cessation contests. She has also utilized this approach to address weight loss among college students. In addition, she is investigating the use of biomarker feedback documenting child exposure to tobacco specific carcinogens to promote smoke free homes. Finally, she is collaborating with the Twin Cities East African community to decrease waterpipe smoking (hookah) in homes and public venues. She has served as an NIH grant reviewer.

Bio

Administrator Info
Name: GI Division
Phone: 612-625-8999
Email: gidivision@umn.edu
Mail: 420 Delaware Street SE, MMC 36, Minneapolis, MN 55455

Summary
Dr. Julie A. Thompson is an Associate Professor of Medicine and has been a faculty member at the University of Minnesota since 2009. She leads the Adult Liver Transplant Program as its Medical Director. Dr. Thompson's clinical interests are in liver transplant medicine and assessment of quality of care. She serves on several Quality and Safety committees in the MHealth system. In addition, she is co-investigator on a number of clinical studies.

Research Summary

• Quality in delivery of medical care
• Alcoholic hepatitis
• Liver Transplantation

Clinical Summary

Hepatology; Transplant; Liver Disease

Bio

Administrator Info
Name: Amy Wang
Email: ausen018@umn.edu

Summary
Dr. Heather Thompson Buum is an Associate Professor of Medicine at the University of Minnesota. She joined the faculty in 2002 and devotes half her time to outpatient general internal medicine/primary care, the other half to various teaching and administrative roles. She formerly served as an Associate Program Director for the Internal Medicine Residency and is now a Course Director for Human Health and Disease in the Medical School and the Interim Division Director for Geriatrics, Palliative and Primary Care. She is also the author of two books: "Mirth is God's Medicine: Coping with Cancer as a Physician'' and "With Mirth and Laughter: Finding Joy in Medicine After Cancer." Dr. Thompson has won numerous awards for teaching and patient care, including Mnpls St. Paul Magazine’s “Top Docs” in 2020, Outstanding Medical School Teacher in 2016, Clinical Excellence Award in 2013, Minnesota Monthly’s “Top Doctors for Women'' in 2013 and 2011, and the Department of Medicine Award for Outstanding Resident Teaching in 2004. She is a member of the Society for General Internal Medicine and a fellow in the American College of Physicians. Her patient care interests include women's health, breast cancer survivorship, hypertension, and also consultative general medicine (the "second opinion" workup.) Dr. Thompson endorses a philosophy of using diet, exercise, and other modalities before resorting to medication or invasive procedures to promote health. Her outside interests include choral music, performing with the Oratorio Society of Minnesota for over 20 years. She also enjoys cooking, running, and an occasional round of golf.

Clinical Summary

Women's health; Preventive medicine; Consultative general medicine

Bio

Administrator Info
Name: GI Division
Phone: 612-625-8999
Email: gidivision@umn.edu
Mail: 420 Delaware Street SE, MMC 36, Minneapolis, MN 55455

Summary
Dr. Thomson graduated from the Medical College of Wisconsin, and completed all of her residency and fellowship training at the University of Michigan.Dr. Thomson's clinical interests include chronic care management in cirrhosis, including patient education, appropriate medication use, and complex care management. She received an AASLD Transplant Hepatology Grant to fund her clinical research efforts.

Research Summary

Chronic care management in cirrhosis Appropriate medication use

Teaching Summary

Chronic liver disease, decompensated cirrhosis, liver transplant

Clinical Summary

Chronic liver disease, decompensated cirrhosis, liver transplant

Bio

Administrator Info
Name: Nephrology Division
Phone: 612-624-9444
Email: renaldiv@umn.edu
Fax: 612-626-3840

Summary
Dr. Peter Thorne joined the faculty at the University of Minnesota in 2022 after completing internal medicine residency and nephrology fellowship at Vanderbilt University Medical Center. Dr. Thorne's clinical interests include chronic kidney disease management, hypertension, and quality improvement. Dr. Thorne has a strong interest in graduate and undergraduate medical education. He is interested in the development of just-in-time teaching tools, development of interactive education sessions, and patient facing education tools.

Research Summary

• Chronic Kidney Disease Progression
• Medical Education Tools

Teaching Summary

Undergraduate Medical Education; Training of Residents and Fellows; Patient Facing Teaching Tools

Clinical Summary

Chronic Kidney Disease Management; Hypertension; Quality Improvement

Bio

Administrator Info
Name: Emily Olmsted-Morales
Phone: 612-624-0999
Email: olmst111@umn.edu
Fax: 612-625-2174

Summary
After completing my undergraduate degree at the University of Minnesota, I received my medical degree from the University of North Carolina. I completed internal medicine residency at New York University prior to returning to Minnesota to complete my fellowship at the University of Minnesota. I am interested in medical education for all levels of trainees, critical care ultrasound, and ARDS. In addition to my clinical responsibilities, I am also the co-director for the pulmonary consult rotation for medical students and residents.

Teaching Summary

Ultrasound training; Medical student, resident, and fellow education, Respiratory physiology

Clinical Summary

ARDS; Ventilator Management; Shock

Bio

Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Mail: 420 Delaware ST SE, MMC 741, Minneapolis, MN 55455

Bio

Administrator Info
Name: Kris Blomquist
Email: krblomqu@umn.edu

Summary
Dr. Tracy graduated from the combined MD/PhD program at Tufts University, receiving his PhD in Immunology. His graduate research focused on the basic biology of the Epstein-Barr Virus. He subsequently completed his residency in Internal Medicine at the Mayo Clinic. During residency, he studied clinical outcomes of patients with lymphoma. He then enrolled in the fellowship program in Hematology, Oncology, and Transplantation at the University of Minnesota, where he was selected for the T32 academic research track. His research now examines mechanisms of immune escape by leukemias and lymphomas. Both his research interest and clinical practice have a particular focus on acute lymphoblastic leukemia. He joined the faculty at the University of Minnesota in 2021.

Research Summary

• Acute lymphoblastic leukemia
• Lymphoma
• Immune therapies

Teaching Summary

“Blood” coursework for medical students

Clinical Summary

Acute lymphoblastic leukemia; Lymphoma; Immune therapies

Bio

Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu

Summary
Dr. Trappey graduated from medical school at Vanderbilt University School of Medicine in 2008 and completed his residency training in Internal Medicine and Pediatrics at the University of Minnesota in 2012. He is currently an Assistant Professor in the Departments of Internal Medicine and Pediatrics where he works as a hospitalist. He is an Associate Director of the Medical School's Center for the Art of Medicine, and his educational and research focus are on the intersection of art and medicine--focusing particularly on reflective writing and medical creative writing. His clinical interests include hospital medicine, medical education, and global health. He is a core-faculty member for the combined Internal Medicine and Pediatrics residency program and serves as the faculty adviser for the Pediatric Global Health Track site at St. Damien Hospital in Port Au Prince, Haiti.

Clinical Summary

Medical reflective writing; Medical education; Global health education

Bio

Administrator Info
Name: GI Division
Phone: 612-625-8999
Email: gidivision@umn.edu
Mail: 420 Delaware Street SE, MMC 36, Minneapolis, MN 55455

Summary
My overarching research interests lie in strategies towards the optimal management of acute pancreatitis and its complications, the most common cause for hospitalization among gastrointestinal diseases. My other main focus has been on exploring modalities for early diagnosis of chronic pancreatitis, a debilitating condition that pose a major detriment to the quality of life of these patients. Other keen interests include pancreatic endo-therapy through endoscopic ultrasound and endoscopic retrograde cholangio-pancreatography for management of complex pancreatic and biliary conditions. I have nearly 50 peer reviewed publications and serve at the American Society of Gastrointestinal Endoscopy' sTechnology committee.

Research Summary

• Management of necrotizing pancreatitis
• Early diagnosis of chronic pancreatitis
• Pancreatic Endotherapy
• Diagnostic and interventional EUS

Teaching Summary

Pancreatology; Therapeutic Endoscopy, Interventional endoscopic ultrasound

Clinical Summary

Endoscopic and multidisciplinary management of complex pancreatic and biliary diseases; Acute and recurrent pancreatitis; Chronic pancreatitis; Necrotizing Pancreatitis; Pancreatic and biliary cancer; Benign bile duct strictures and injuries

Bio

Administrator Info
Name: Becca Johnson
Phone: 612-624-9996
Fax: 612-625-4410
Email: joh07913@umn.edu
Mail: Mayo Memorial Building, MMC 250, 420 Delaware Street S.E., Minneapolis, MN 55455 

Summary
Dr. Trivedi has completed her medical school from B.J.Medical College & Civil Hospital, Ahmedabad, Gujarat, India. Afterward, she pursued MS in Biomedical Sciences from the University of Kentucky with a primary focus on Microbiology, Immunology, and clinical and translational research. She has completed postgraduate training in Internal Medicine residency and Infectious Diseases fellowship from the State University of New York at Buffalo. Dr. Trivedi cares for adult patients who have or are suspected of having infectious diseases in hospital or outpatient clinic settings. Her research has focused on various mechanisms of antibiotic resistance in gram-negative bacteria and, most recently during fellowship, on evaluating a drug target in the XDR strain of Acinetobacter baumanii. She is also interested in clinical research. Moreover, she has a keen interest in medical education, emphasizing various strategies to support active learning with different levels of learners, whether during bedside rounds or in a classroom setting.

Research Summary

• Microbial pathogenesis
• Clinical research
• Disparities in healthcare and medical education

Teaching Summary

Evidence-based Medicine, Resident/Fellow as Educator curriculum

Clinical Summary

MDR and XDR Gram-negative infections ; Cardiovascular infections ; CNS infections

Bio

Administrator Info
Email: endofixer@umn.edu
Mail: 420 Delaware Street SE
MMC 101
Minneapolis, MN 55455

Summary
Dr. Susanne Trost after graduating from medical school did a post-doctoral research fellowship at the University of California, San Diego. Thereafter she completed her residency and in 2006 finished her fellowship in Endocrinology, Diabetes and Metabolism at the University of Vermont Medical Center. She worked at Gifford Medical Center as an Endocrinologist and switched to Central Vermont Medical Center, University of Vermont Health Network. She joined the Osteoporosis Program at the University of Vermont Medical Center in 2015.

Clinical Summary

Osteoporosis; Thyroid Nodules; Diabetes Type 1 and 2

Bio

Kamil Ugurbil currently holds the McKnight Presidential Endowed Chair Professorship and is the founding Director of the Center for Magnetic Resonance Research (CMRR) at the University of Minnesota. After completing his B.A. and Ph.D. degrees in physics, and chemical physics, respectively, at Columbia University, New York, N.Y., Prof. Ugurbil  joined AT&T Bell Laboratories in 1977, and subsequently returned to Columbia as a faculty member in 1979. He was recruited to the University of Minnesota in 1982 where his research in magnetic resonance led to the evolution of his laboratory into an interdepartmental and interdisciplinary research center, the CMRR. His primary research focus has been the development and application of MR methods and instrumentation towards obtaining high spatiotemporal resolution and high accuracy functional and anatomical information in the human brain, and the development of ultrahigh magnetic fields for human imaging for biomedical research in general. This body of work has culminated in pioneering accomplishments, such as the co-introduction of functional brain imaging (fMRI), the introduction and development of ultrahigh magnetic fields (defined as ≥7 Tesla), functional mapping of columnar and layer specific functional responses in the human brain, highly accelerated functional brain imaging, and MR spectroscopy for studies of metabolism in vivo. He was one of the two PI’s of the Human Connectome Project and one of the fourteen members of the first BRAIN Initiative working group. He was recognized by several awards and honors including membership in the US National Academy of Medicine, American Academy of Arts and Sciences, Richard R. Ernst Gold Medal, ISMRM Gold Medal, ISMAR Prize, Koç Award, the IEEE Medal for Innovations in Healthcare Technology, and two honorary doctorates.

Research Summary

Kamil Ugurbil's central research interest is tackling biological problems, particularly in the brain, with new and transformative imaging technologies that involve instrumentation, image acquisition and reconstruction methods. His research is characterized by development of new technologies, and applications of these technologies, to obtain new and previously unavailable information about biological processes. This central interest was initially focused on developing, for the first time, new magnetic resonance (MR) spectroscopy methods to monitor intracellular chemistry in intact biological systems, using systems such as bacteria in suspension and perfused organs. This work pioneered the general field of using MR for the study of biological processes in vivo. In the past three decades, his focus has predominantly been the development of ultrahigh field MR methods for human neuroimaging, particularly for imaging brain activity (functional imaging (fMRI)) and connectivity and combining these methodological and instrumentation developments with neuroscience applications in the human and animal brain to advance our understanding of brain function in health and disease.

Dr. Ugurbil's research brings together physics and instrumentation with physiology, neuroscience and neurochemistry to assess cerebral function. fMRI was first achieved simultaneously by two independent teams; one was the team he lead at the Center for Magnetic Resonance Research (CMRR) at the University of Minnesota. This development has been followed by a large body of seminal work from his laboratory on the mechanisms of coupling between magnetic resonance detected signals and neuronal activity, and development of new instrumentation and techniques to exploit this information, leading to the most advanced neuroimaging studies we have today. 
The effort of his group to develop new technologies to advance neuroimaging pioneered the use of ultrahigh field (≥7 Tesla) imaging in humans, particularly (but not only) for pushing the boundaries of mapping brain function and connectivity. 7 Tesla and associated methods developed to overcome the significant challenges faced with imaging the human body at such high magnetic fields currently represent the most advanced platform used for human brain research and are now increasingly used world-wide. This effort also led to the development of instrumentation capable of human imaging above 10 Tesla for the first time (see the article The world’s strongest MRI machines are pushing human imaging to new limits).

Recently, these advances have been extended to mapping the macro-connectome of the human brain under the auspices of the Human Brain Connectome project launched by the NIH Neuroscience Blueprint initiative and continued through Human Connectome Project Lifespan project.

Bio

Administrator Info
Name: Mayna Xiong
Email: xion2253@umn.edu
Mail: Lillehei Heart Institute
2231 6th Street SE
1st-floor Mailroom CCRB
Minneapolis, Minnesota 55455

Summary
After obtaining his M.D. and Ph.D. degrees from the University of Maastricht, the Netherlands, Dr. Jop van Berlo performed postdoctoral research with Dr.Jeffery Molkentin at the Howard Hughes Medical Institute, Cincinnati Children's Hospital Medical Center. Upon joining the University of Minnesota he has built a research program focused on the cellular and molecular mechanisms of cardiac remodeling and regeneration. An active area of research is on the role of the immune system in orchestrating cardiac remodeling. Separately, the laboratory is interested in discovering regulators of cardiomyocyte proliferation.

Research Summary

My laboratory studies the cellular and molecular mechanisms of cardiac remodeling and regeneration. The goal of this research is to develop innovative strategies to enhance the limited ability of the heart to regenerate and stimulate reverse remodeling. To identify these strategies, we study the underlying mechanisms of endogenous remodeling and regeneration in mice. We are currently interested in discovering novel regulators of cardiomyocyte proliferation. We have candidate regulators that we are verifying in cell culture and in genetic mouse models. Furthermore, we are interested in the role of the immune system in orchestrating remodeling and regeneration.

Bio

Administrator Info 
Name: Roberta Beach
Phone: 
Email: rmbeach@umphysicians.umn.edu
Fax: 
Mail: 420 Delaware ST SE
MMC 508
Minneapolis, MN 55455

Summary
Jeremy Van't Hof is a Minnesota native who traveled to Michigan for undergraduate training in biochemistry (Calvin College) and then to California for medical school (Loma Linda University). Informing his lifelong interest in public health, he spent a key five month period in Honduras as a rural health clinic volunteer performing rural medicine outreach. He returned to Minnesota in 2012 in order to complete an Internal Medicine Residency and Cardiovascular Medicine Fellowship at the University of Minnesota.Dr. Van't Hof's clinical interests include early detection of cardiovascular disease in order to prevent or delay the onset of cardiovascular events, familial hypercholesterolemia, resistant hypertension and complex polyvascular disease. He believes in an integrative treatment approach combining lifestyle alterations with evidence based medical therapy to maximize physical and mental health as well as quality of life. Dr. Van't Hof's research interest involves improving cardiovascular disease detection and early intervention. He believes that poor cardiovascular health is often a result of poor public health literacy, linked to inefficiencies created by the current "sickness-based" health care delivery system. The failure of cardiovascular prevention is a key factor that leads individuals to a less happy, less productive, and shorter life. Dr. Van't Hof is dedicated to all efforts that improve both individual cardiovascular health and population health through public health research and intervention.

Research Summary

• Early cardiovascular disease detection and intervention
• Appropriate screening for cardiovascular diseases
• Bridging the gap between public health and precision medicine

Clinical Summary

Cardiovascular disease prevention (primary, secondary), Early detection of cardiovascular disease, Epidemiology, Familial hypercholesterolemia, Lipid/cholesterol disorders, Premature atherosclerosis, Resistant hypertension, Wellness/Integrative Medicine

Bio

Administrator Info
Name: GI Division
Phone: 612-625-8999
Email: gidivision@umn.edu
Mail: 420 Delaware Street SE, MMC 36, Minneapolis, MN 55455

Summary
Dr. Vaughn completed his Internal Medicine residency and Gastroenterology fellowship at Beth-Israel Deaconess Medical Center in Boston. There he developed both clinical and research interests in Inflammatory Bowel Disease. He worked with the IBD Center at BIDMC to study the effect of therapeutic manipulation of the microbiome in Crohn's disease as well as optimizing the management of anti-TNF medications. In addition to his research interests he has worked closely with the medical school teaching students and mentoring physicians in training in clinical and quality improvement research. His main clinical interests include Crohn's disease, Ulcerative Colitis as well as Microscopic colitis and Celiac disease. He also sees patients with recurrent C. difficile colitis. His active areas of research involve clinical trials for IBD.

Research Summary

Dr. Vaughn is actively involved in both clinical and translational research for patient with IBD. The intestinal microbiota has recently been identified as a critical component of many intestinal pathways including immune tolerance and inflammation. Dr. Vaughn is working in collaboration with Dr. Alexander Khoruts to continue to understand how the microbiota functions to induce inflammation or tolerance. Additionally, Dr. Vaughn has been a strong proponent for therapeutic drug monitoring. This includes monitoring drug levels for patient on anti-TNFs such as infliximab and adalimumab. His research demonstrates that by close monitoring of these medication and titration to a therapeutic window, patients have more effective disease control and less chance of developing anti-drug antibodies.He continues to study the effect of therapeutic drug monitoring on antibody development.

Clinical Summary

Inflammatory Bowel Disease; Clinical trials in IBD; Crohn's Disease; Ulcerative Colitis; Microscopic colitis

Bio

Administrator Info
Name: Linsey Roschen
Email: rosch053@umn.edu

Summary
For over 40 years at the University of Minnesota, Dr. Vercellotti has focused on studies of inflammation, oxidative stress, vascular biology, atherosclerosis, and sickle cell disease (SCD). His laboratory pioneered investigations of how the vasculature can adapt to oxidative stress and hemoglobin/heme by inducing cellular cytoprotectants including heme oxygenase-1, carbon monoxide, and ferritin. Using transgenic sickle mice, innovative models to study vaso-occlusion, and novel gene therapy techniques, his laboratory defined the pathologic role of hemolysis in vaso-occulsion and established the paramount importance of dealing with hemolysis by detoxifying heme with heme oxygenase and the anti-inflammatory properties of carbon monoxide. His lab has developed a robust and reproducible dorsal skin-fold chamber method that measures vaso-occlusion in sickle mice and allows the in vivo testing of drugs affecting vaso-occlusion. He and colleagues have previously used gene therapy with Sleeping Beauty transposons to overexpress heme oxygenase-1, the heme binding protein hemopexin, and the iron-binding protein heavy chain ferritin in the livers of SCD mice, as well as erythroid-specific expression of non-sickling adult beta-globin in primary CD34+ cells. Recent work has shown that heme released from sickle RBCs interacts with the innate immune toll-like receptor 4 (TLR4) on endothelium and blood cells to activate pro-inflammatory signaling in SCD. Current work is focused on discovering novel therapeutic approaches to modulate TLR4 signaling with targeted inhibitors.

Research Summary

Dr. Vercellotti's research focuses on inflammation and endothelial cell biology, the role of inflammation in vaso-occlusion in sickle cell anemia, the role of infection in atherosclerosis and vascular disease, and oxidative stress and vascular disease. His clinical interests range from coagulation and bleeding disorders, platelet disorders, red cell disorders, porphyria, bone marrow transplant, leukemia, lymphoma, and myeloma to immunologic deficiencies.Dr. Vercellotti's lab demonstrated that the abundant physiological iron contained in heme, is a powerful catalyst for LDL oxidation which could activate and damage endothelial cells. Heme readily enters cell membranes and the endothelium becomes hyper- susceptible to oxidant-mediated cytolysis. They demonstrated how the vasculature defends itself against heme mediated injury by the induction of the cellular cytoprotectants, heme oxygenase-1 (HO-1) and ferritin, leading to resistance to oxidant-mediated injury. They showed in vivo relevance of this cytoprotection in a variety of models from rhabdomyolysis to sickle cell disease (SCD). His lab provided significant evidence for the important role of inflammation in vaso-occlusion in SCD. They demonstrated that decreasing inflammation or decreasing reactive oxygen species, inhibiting adhesion molecules, all decrease vaso-occlusion in murine models of sickle cell disease using a unique physiological model. Due to hemolysis, both human SCD and murine SCD model have increased HO-1. They demonstrated that HO-1, when overexpressed in sickle animals, prevents hypoxia induced vaso-occlusion. Furthermore, the products of HO-1, biliverdin and CO could also modulate vaso-occlusion.Recent work has shown that heme released from sickle RBCs interacts with the innate immune toll-like receptor 4 (TLR4) on endothelium and blood cells to activate pro-inflammatory signaling in SCD. Current work is focused on discovering novel therapeutic approaches to modulate vaso-occlusion with targeted inhibitors of TLR4, complement and BACH1. He is also collaborating on developing gene therapies and gene editing for sickle cell disease. He is a co-investigator on clinical trials for gene therapy for sickle cell disease and pi for trials for gene editing for thalassemia.

Teaching Summary

Dr. Vercellotti's entire career has been focused on education. Multiple undergraduate, graduate, and, postdoctoral students, as well as residents and fellows, have rotated in his laboratory and have become faculty members at prestigious medical centers around the world. His love of education and mentoring is reflected by his experiences in directing internal medicine clerkships, directing the 2nd year hematology blood course, developing objectives with colleagues of the American Society for Hematology for all medical schools for 2nd year medical school blood courses, and serving for 7 years as Senior Associate Dean for Education, overseeing all aspects of medical education, ranging from admissions, curriculum, MD/PhD program, Graduate Medical Education, Continuing Medical Education, Allied Health, and programs to advance diversity in our health care profession. He has overseen the T32 grant for training in Hematology since 2010, developed new curriculum for Responsible Conduct of Research, and grant writing skills for future scientists. The training grant in hematology for 45 years has trained national and international leaders in hematology. Today the program continues to successfully prepare physicians and scientists for research careers as evidenced by the high percentage of T32 trainees that are academic or industry scientists. He has been involved in the MSTP and PSTP programs since their inception. 

Clinical Summary

Sickle Cell Disease, Thalassemia, Hemochromatosis, Iron-related disease, Porphyria, Anemia, White Blood Cell Disorders, Blood and Marrow Transplantation and Immunodeficiency

Bio

Administrator Info
Email: cviolato@umn.edu

Summary
Professor and Assistant Dean, Assessment, Evaluation and Research at the University of Minnesota Medical SchoolDr. Violato has taught at and held leadership positions at Wake Forest School of Medicine, the University of Calgary, University of British Columbia, University of Victoria, and the University of Alberta. Dr. Violato's publications in medical education include competency based assessment, psychometrics, research methods, leadership, and clinical reasoning and cognition. In addition to 10 books, Dr. Violato has published more than 300 scientific and technical articles, abstracts and reports in major journals such as Academic Medicine, Medical Education, British Medical Journal, Canadian Medical Association Journal, and the Lancet. He has received millions of dollars in research funding from various institutions including the US National Institute of Health. His most recent book, Assessing Competence in Medicine and Allied Health Professions is published by Taylor & Francis, 2019.

Research Summary

• Psychometrics and research methods
• Biostatistics
• Medical education research

Teaching Summary

• Psychometrics and research methods
• Biostatistics
• Medical Education Research

Bio

Administrator Info
Name: GI Division
Phone: 612-625-8999
Email: gidivision@umn.edu
Mail: 420 Delaware Street SE, MMC 36, Minneapolis, MN 55455

Summary
Dr. Viskocil is an Assistant Professor of Medicine at the University of Minnesota. She is originally from Wisconsin and her undergraduate education was at the University of Iowa. She moved to the Twin Cities to attend medical school at the University of Minnesota. She completed her internal medicine residency training at the University of Minnesota and stayed on as a Chief Resident focusing on resident education. Her gastroenterology fellowship was done at the University of Minnesota as well.Dr. Viskocil has several areas of focus including educating future physicians and treating disorders of the gut-brain interaction, such as IBS. Chronic gastrointestinal illnesses, such as these, require a team-based approach to care. Our patient-centered care aims to meet the personal needs of each patient, assist in management of daily symptoms, and improve overall quality of life.

Teaching Summary

Course Director; Gastroenterology; Health and Human Diseases; Year 2 Medical School

Clinical Summary

Disorders of the Gut-Brain Interaction (Functional Gastrointestinal Disorders)

Bio

Administrator Info
Name: Emily Awes Anderson
Phone: 612-624-0999
Email: awes0005@umn.edu
Fax: 612-625-2174

Summary
Dr. Wacker combines medical training in emergency medicine, internal medicine and medical critical care with a research background in molecular biology and biophysics.

Research Summary

Shock, ARDS, Oncological emergencies

Clinical Summary

Shock, Respiratory failure, Oncological emergencies

Bio

Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189

Summary
Hospital medicine, Undergraduate and Graduate Medical Education, Patient communication

Research Summary

• Medical education
• Point of Care Ultrasound 

Teaching Summary

• Undergraduate and Graduate Medical education
• Point of Care Ultrasound in Hospital medicine

Clinical Summary

• Hospital medicine
• Internal Medicine and Pediatrics
• Proceduralist

Bio

Administrator Info
Name: Gail Hannan
Email: ghannan@umn.edu
Mail: 420 Delaware Street SE
MMC 741
Minneapolis MN 55455

Summary
Dr. Webber is an Assistant Professor of Medicine at the University of Minnesota. He attended medical school at the Loyola University Chicago Stritch School of Medicine before completing his Internal Medicine Residency at the University of Minnesota where he also served as Chief Resident. He currently practices Hospital Medicine at the MHealth Fairview University of Minnesota Medical Center East Bank.

Dr. Webber served as the Medical Director of Units 5B and 6B at the University of Minnesota Medical Center East Bank before being named the Senior Medical Director of Adult Medical/Surgical Units on the East Bank. He has interest in quality improvement, resident and faculty education, and sepsis care.

Dr. Webber also serves as the Associate Vice Chair of Clinical Affairs for the Department of Medicine, in which he leads initiatives to improve clinical operations, quality and safety of care across the breadth of clinical services and practice locations. 

Research Summary

• Medical Education
• Sepsis

Teaching Summary

• ECM

Clinical Summary

• Sepsis

Bio

Administrator Info
Name: OFAD
Phone: 612-624-2909
Email: dom-ofad@umn.edu
Fax: 612-626-3107
Mail: 420 Delaware ST SE
MMC 194
Minneapolis, MN 55455

Summary
Dr. Weber-Main's interests and expertise are in research faculty development, with concentrations in scientific/medical writing and mentoring models. She is a prolific scientific writing and career advancement mentor for faculty/fellows across the health sciences. In addition to earning her PhD in chemistry, she completed a Mass Media Science and Engineering Fellowship through the American Association for the Advancement of Science and earned two editing/writing certificates from the American Medical Writers Association. Her extensive teaching experience includes development of the Proposal Preparation Program, a longitudinal grant writing workshop series for early-career faculty. She adapted this successful curriculum for national dissemination through the NIH-funded National Research Mentoring Network, which supports the career advancement of research trainees from under-represented groups in biomedical disciplines. She has developed several online training modules for the professional development of mentors. Currently, she co-directs the Mentoring Excellence Training Academy for the University of Minnesota's Clinical and Translational Sciences Institute.

Bio

Administrator Info
Mail: 420 Delaware ST SE
MMC 480
Minneapolis, MN 55455

Summary
Dr. Weisdorf is Professor of Medicine and Deputy Director, University of Minnesota Clinical and Translational Science Institute. Dr. Weisdorf serves as the Senior Research Advisor for the Center for International Blood and Marrow Transplant Research. At the University of Minnesota, he was the Director of the Division of Hematology, Oncology and Transplantation (2013-2018), Director of Adult Blood and Marrow Transplant Program (1998-2017) and served as the Principal Investigator on the NIH-sponsored Blood and Marrow Transplantation Clinical Trials Network and Chair of the Network Steering Committee (2001-2016).Dr. Weisdorf received his M.D. in 1975 from the Chicago Medical School and received Internal Medicine training at Michael Reese Hospital in Chicago. He was a Fellow at the University of Minnesota in Hematology and Medical Oncology and is Board certified in both disciplines.

Research Summary

Dr. Weisdorf's clinical and research interests are in application of blood and marrow transplant therapies for hematologic malignancies as well as extensive study of the clinical complications of transplantation including opportunistic infections and graft versus host disease (GVHD).

Bio

Dr. Wendt has a long-standing interest in clinical and translational research in COPD, specifically focusing on biomarkers and pathways of disease. Dr. Wendt has participated on five large NIH COPD trials, three of which are ongoing and are a resource for developing trainees and junior faculty interested in clinical research. In addition, Dr. Wendt was recently the PI of a FAMRI award for a clinical trial related to the microbiome. This study provided a platform for a junior faculty (CDA awardee) to gain experience in clinical trials and to participate in the expansion to a multi-center trial. Dr. Wendt's current translational work has focuses on biomarkers and causal pathways in COPD leading to lung cancer (VA Lung Precision Oncology Program) and HIV associated COPD (NIH R01). These translational projects combine multiple investigators with expertise in genomics, transcriptomics, proteomics, computational and systems biology. Dr. Wendt also participates in a VA Cooperative Study (SHADE) to determine the respiratory effects of particulate matter in deployed Veterans and has a VA Collaborative Merit Award to phenotype exposure related pulmonary disease in the SHADE cohort. Through all this work Dr. Wendt has fostered cross-discipline collaborations, creating mentoring and collaborative opportunities for trainees and junior faculty. Dr. Wendt has and continues to accumulate a substantial and successful mentoring record. Dr. Wendt has mentored 5 graduate students,11 fellows, 3 PhD post-doctoral fellows and 5 faculty. Most notably are Dr. Alexa Pragman, recipient of VA CDA and recent VA Merit Award (microbiome in COPD), Dr. Theresa Laguna, recipient of NIH R01 (microbiome in CF infants) and recently recruited as Division Director of Pulmonary, Northwestern University, Dr. Maneesh Bhargava, recipient of CTSI K award and NIH R01, Dr. Arianne Baldomero, recipient of CTSI KL2 Award, Dr. Dwight Stoll, Professor and Co-Chair of Chemistry at Gustavus University and Dr. Filippo Colleti, Aerospace Engineering, recipient of NIH R22 (structure-function in COPD) and promoted to Associate Professor with tenure. Dr. Wendt also has extensive involvement with the American Thoracic Society (ATS) including chairing multiple assembly committees, which is a resource for networking and involvement for trainees and junior faculty.

Research Summary

Dr. Wendt’s research has focused on both clinical and translational research in COPD and associated contributors including tobacco, HIV, air pollution and COPD as a causal pathway to lung cancer. Dr. Wendt has participated on five large NIH COPD trials, including the NIH COPD Clinical Research Network and COPDGene. A significant area of focus includes identifying biomarkers and pathways of disease, particularly in lung cancer and HIV associated COPD. This translational program combines multiple investigators with expertise in genomics, transcriptomics, proteomics, computational and systems biology. Much of this work has included applying mass spectrometry techniques to measure proteins and metabolites in bronchoalveolar lavage fluid (BALF). This includes the development of a robust protocol to perform mass spectrometry, high throughput proteomics on small volumes of BALF. This workflow is highlighted in a recent publication and part of Dr. Wendt’s participation in an ATS document on BALF. Using this robust technique has led to new discoveries in proteomic and metabolic pathways in HIV-associated COPD and the role of complicated protease networks. 

Dr. Wendt’s interest in air pollution and chronic lung disease dates to her participation as a delegate for the University of Minnesota and Chinese Academy of Science to address the health effects of air pollution in China. This resulted in two publications on the effects of air pollution exposure on lung disease and biomarkers of lung disease. Following this she became a Site PI for the VA Cooperative Study #595 Service and Health Among Deployed Veterans (SHADE). SHADE is an epidemiology study to determine the effects of deployment-related air pollution exposure, including burn pits, on lung function and symptoms. This study uses sophisticated modeling to identify individual air pollution exposure to correlate to lung function and symptoms. To further characterize this population, Dr. Wendt was awarded a VA Merit Award as part of a Cooperative Merit Award to characterize biomarkers of airway injury and inflammation in a subset of SHADE participants with respiratory symptoms. These biomarkers in combination with assessment of anatomical and structural changes on chest computed tomography and airway physiology in the same Veteran population will allow detailed characterization of respiratory endotypes related to PM2.5 exposure. In addition, using the VA Corporate Data Warehouse (CDW) we have identified over 1.2 million Veterans with COPD and using this unique cohort is in collaboration with Dr. Berman, Environmental Sciences, to determine the association of air pollution and mortality in a vulnerable population.

Clinical Summary

Clinical Interests COPD; Critical Care Clinic Focus My major clinical focus has been on advanced therapies for emphysema. I am the Co-Director of the Lung Volume Reduction Surgery Program and I am currently participating on the NIH COPD Clinical Research Network. The University of Minnesota has been designated the clinical coordinating center for this network.

Bio

Dr. Wernimont received her MD and PhD as part of the Medical Scientist Training Program at the University of Wisconsin School of Medicine and Public Health. For her PhD, she studied basic mechanisms of T cell activation. Afterwards, she completed her residency in Obstetrics and Gynecology and fellowship in Maternal-Fetal Medicine at the University of Iowa, as part of their Physician Scientist Training Program. Dr. Wernimont joined the University of Minnesota in 2020 and her research is currently funded through the NIH Reproductive Scientist Development Program. In addition to caring for patients with complicated pregnancies, she has a strong research interest in improving care delivery for pregnant patients with diabetes and fetal growth abnormalities.

Research Summary

Dr. Wernimont’s research interests are directed towards improving outcomes for people with pregnancies complicated by diabetes and obesity. In her clinical research, she has worked to develop
and identify better ways to deliver care for patients with diabetes in pregnancy. Towards this end, she recently created the University of Minnesota Obstetric Measures (UMOMs) database that includes over
70,000 patients and 100,000 deliveries from the MHealth/Fairview System. She has used this database to examine timing of delivery in pregnancies complicated by diabetes and how providers define “poor
glucose control.” She is currently leading a multi-department effort to establish a biorepository for systematic collection of maternal, placental, and neonatal samples to support translational research across the perinatal spectrum at the University of Minnesota to link with clinical data within the UMOMs database. The resulting biorepository is termed UMOM:GOPHER (University of Minnesota Obstetric Measures--Gestational Outcomes and Pediatric HEalth Repository). In her basic science, Dr. Wernimont studies how the maternal nutritional-metabolic environment impacts placental development, function and long-term health outcomes. Using both human placental specimens and trophoblast cell lines, Dr. Wernimont combines cutting edge metabolomics and transcriptomics to define the mechanisms by which changes in nutrient availability impact trophoblast differentiation. The long term goal of this work is to develop novel strategies to improve pregnancy health and childhood outcomes in pregnancies complicated by diabetes.

Clinical Summary

Clinical interests:
Diabetes and obesity in pregnancy; Fetal Growth Abnormalities

Bio

Administrator Info
Name: Colleen Doyle
Email: doyl0050@umn.edu

Summary
Dr. White is a board certified clinical health psychologist and Assistant Professor in the Department of Medicine at the University of Minnesota. She earned her Ph.D. in clinical psychology from the University of South Florida and completed a 2-year postdoctoral fellowship in primary care behavioral health in the Department of Family Medicine and Community Health at the University of Minnesota. Prior to joining the University of Minnesota, Dr. White worked as an integrated primary care psychologist at Hennepin Healthcare. Dr. White specializes in health psychology and behavioral medicine with clinical expertise in stress, anxiety, and the biopsychosocial aspects of cardiovascular disease, diabetes, and obesity. She also has a passion for health equity and social justice. Dr. White’s primary area of interest is in the overlap among health psychology, behavioral medicine, and environmental sustainability. Specifically, she is interested in taking an environmental justice perspective to promote equitable human and environmental co-benefit solutions, using her academic training as a stress researcher to guide her work.

Research Summary

• The stress-reducing and health-promoting effects of restorative natural environments
• Environmental and human health co-benefit solutions
• The role of environmental sustainability in human well-being
• Environmental justice
• The health impacts of climate change
• The health benefits of climate solutions
• The symbiotic relationship between humans and the natural environment

Clinical Summary

Stress reduction, anxiety management, health promotion and disease prevention, inflammatory illness, cardiovascular disease, diabetes, obesity, physical and mental health impacts of climate change, and health benefits of climate solutions

Bio

Administrator Info
Name: Colleen Doyle
Email: doyl0050@umn.edu

Summary
Dr. Williams is a Native American physician with an interest in caring for complex medical care of adult diverse populations, with a special interest in Native American peoples. Prior to coming to the University of Minnesota, Dr. Williams was a Complex Primary Care provider for M Health Fairview in Eagan and prior to this was Assistant Dean for Diversity and Inclusion when he was at the University of South Dakota Sanford School of Medicine while being a hospitalist. Research interest involving health inequities with special interest in rural and urban Native American populations.

Research Summary

Research interest involving health inequities with a special interest in rural and urban Native American populations

Teaching Summary

Research interest involving health inequities with a special interest in rural and urban Native American populations

Clinical Summary

Complex social and medical care

Bio

Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Phone Number: 612-624-0579
Fax Number: 612-624-3189

Summary
Angelica Willis recently joined the Departments of Medicine and Pediatrics at the University of Minnesota as a Med-Peds Hospitalist. She completed medical school and a Master of Public Health in Epidemiology at the University of Michigan. She then completed residency in Internal Medicine and Pediatrics at the Medical College of Wisconsin. Outside of clinical work, she enjoys teaching medical students and residents, as well as health equity work.

Research Summary

• Medical Education
• Diversity, Equity, and Inclusion

Teaching Summary

• Health Equity
• Public Health for Clinicians

Clinical Summary

• Hospital Medicine

Bio

Administrator Info
Fax: 420 Delaware Street SE
MMC 508 Mayo
8508A (Campus Delivery Code)
Minneapolis, MN 55455

Summary
Dr. Wilson has dedicated his professional life to developing new methods for diagnosing and treating heart disease, and to training new physicians.A graduate of the University of Iowa College of Medicine, Dr. Wilson completed his residency at the University of Texas Health Science Center at San Antonio and his cardiology fellowship at the University of Iowa. He joined the University of Minnesota faculty in 1986, when he and Dr. Carl White established a training program that has graduated over 60 interventional cardiologists. From 1988-2004, Dr. Wilson served as the director of the University of Minnesota Medical Center cardiac catheterization laboratory. From 2008 to 2013 he served as the chief of Clinical Cardiology.Dr. Wilson's investigative career initially focused on coronary physiology in humans. He developed the first catheter for the selective measure of coronary blood flow in humans, and described the effects of atherosclerosis and transplantation on coronary blood flow. He also first identified reinnervation of the transplanted human heart and its effects on cardiac function. Later, Dr. Wilson developed semi-computerized injection systems for coronary angiography that now used annually for millions of patients worldwide.Dr. Wilson's present research focus is the development of a prosthetic heart valve that can be inserted through a small catheter, eliminating the need for open-heart valve surgery. This device is now in human clinical trials. He also developed a platform for shielding hospital personnel from harmful scatter radiation during cardiac procedures. That system is in use across the nation.Dr. Wilson holds numerous patents for cardiovascular treatment devices and has published over 100 scientific papers. The National Institute of Health, the American Heart Association, and private individuals have supported his work.

Clinical Summary

Coronary artery disease and intervention, Coronary artery disease (stable and unstable angina, myocardial, infarction), Coronary physiology, Endothelial dysfunction (blood vessel disease), Interventional cardiology, Invasive hemodynamics, Transcatheter therapies

Bio

Administrator Info
Name: Nephrology Division
Phone: 612-624-9444
Email: renaldiv@umn.edu
Fax: 612-626-3840

Summary
Dr. Katti Woerner earned her medical degree from Kansas City University. She completed her Internal Medicine Residency at Hennepin County Medical Center and her Nephrology Fellowship at the University of Minnesota.Dr. Woerner's clinical interests include Chronic Kidney Disease, general nephrology, and polycystic kidney disease. Dr. Woerner is a University of Minnesota Physician, her clinic is at M Health Fairview Clinics and Surgery Center - Maple Grove.

Clinical Summary

• Chronic Kidney Disease
• General Nephrology
• Polycystic Kidney Disease

Bio

Administrative Assistant Name
Alicia Anderson

Administrative Email
akanders@umn.edu

Susan M. Wolf is a Regents Professor; McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre Baker Daniels Professor of Law and Professor of Law & Medicine at the University of Minnesota Law School; and a Professor of Medicine at the University of Minnesota Medical School. She is also Founding Chair of the University's Consortium on Law and Values in Health, Environment & the Life Sciences. She received her A.B. summa cum laude from Princeton University in 1975 and her J.D. from Yale Law School in 1980, with graduate work at Harvard University.

Professor Wolf is an elected member of the National Academy of Medicine, an elected fellow of the American Association for the Advancement of Science (AAAS), and an elected fellow of The Hastings Center as well as a past-member of the Fellows’ Council. She is a past member of the American Society for Bioethics and Humanities (ASBH) Board of Directors (elected) and former Chair of the Association of American Law Schools (AALS) Section on Law, Medicine and Health Care. She has received numerous grants to support her research, including from the National Institutes of Health (NIH), National Science Foundation (NSF), and The Greenwall Foundation. In 2007-10 she served as a member of the Law & Neuroscience Project funded by the MacArthur Foundation. She has served as a senior consultant to The Hastings Center to produce revised guidelines for end-of-life care, funded by the Donaghue Foundation and Sussman Trust and published in 2013. In 2012, she received a Robert Wood Johnson (RWJF) Investigator Award in Health Policy Research to fund research in 2012-14.

After graduating from Yale Law School, she clerked for a federal judge and practiced law for several years at Paul, Weiss, Rifkind, Wharton & Garrison in New York. In 1984 she became a National Endowment for the Humanities (NEH) Fellow and then Associate for Law at The Hastings Center, a not-for-profit research institute now in Garrison, NY, specializing in biomedical ethics. She also taught law and medicine at New York University Law School for six years as an Adjunct Associate Professor. She was a Fellow in the Program in Ethics and the Professions at Harvard University in 1992-93, before joining the Minnesota faculty in the Fall of 1993.

Professor Wolf has served on a variety of governmental and institutional panels, including for the National Institutes of Health (NIH) and National Academies of Sciences, Engineering, and Medicine (NASEM), as well as the American Bar Association (ABA) Coordinating Group on Bioethics and the Law, American Society for Reproductive Medicine (ASRM) Ethics Committee, New York City AIDS Review Panel, and Memorial Sloan-Kettering Cancer Center Ethics Committee. In 2011, she was appointed by the Secretary of Health & Human Services to the National Science Advisory Board for Biosecurity (NSABB). She has served on the Editorial Board for the Journal of Law, Medicine & Ethics; American Journal of Bioethics (AJOB); Journal of Urban Health; and Journal of Women's Health and Law; and as Faculty Advisor to the Minnesota Journal of Law, Science & Technology. She has lectured widely, in the United States and abroad.

Professor Wolf is the author or coauthor of numerous articles and book chapters that have appeared in the New England Journal of Medicine, JAMA, Science, American Journal of Public Health, Hastings Center Report, Kennedy Institute of Ethics Journal, American Journal of Law & Medicine, Journal of Law, Medicine & Ethics, various law reviews, and other publications. She directed the Hastings Center project that produced the influential book, Guidelines on the Termination of Life-Sustaining Treatment and the Care of the Dying (Indiana University Press, 1987), is coauthor of the revised Guidelines published by Oxford University Press in 2013, as well as editor of Feminism & Bioethics: Beyond Reproduction (Oxford University Press, 1996). She writes frequently on death and dying, assisted suicide and euthanasia, genetics and genomics, assisted reproduction, women's health care, managed care, and other topics in health law, law and science, and bioethics.

For Professor Wolf's Law School bio and list of publications with links, see her Law School profile.

Awards & Recognition

• Regents Professor, University of Minnesota (2021-present)
• Co-lead, Minnesota COVID Ethics Collaborative (MCEC) (2020-22)
• Uniform Law Commission Health Care Decisions Act, past member, Study Committee, then Observer, Drafting Committee (2020-present)
• Distinguished Lecturer, Hagler Institute for Advanced Study, Texas
  A&M University (2019-20)
• National Academies, Reviewer, Returning Individual Research Results
  to Participants (2018)
• Member, National Institutes of Health (NIH), National Heart, Lung,
  and Blood Institute (NHLBI), Trans-Omics for Precision Medicine (TOPMed) Program, External Advisory Panel (2017-22)
• Member, National Academies of Sciences, Engineering, and Medicine
  (NASEM), Strategic Council for Research Excellence, Integrity, and Trust (2021-present)
• Member, National Academies of Sciences, Engineering, and Medicine
  (NASEM), Committee on Science, Engineering, Medicine, and Public Policy (COSEMPUP) (2016-present)
• McDonald-Merrill-Ketcham Award for Excellence in Law & Medicine,
  Indiana University (2015)
• Member, National Science Advisory Board for Biosecurity (NSABB)
  (2013-16)
• Institute of Medicine (IOM), National Academies, Reviewer, Oversight
  and Review of Clinical Gene Transfer Protocols (2013)
• Member, National Institutes of Health (NIH), National Human Genome
  Research Institute (NHGRI) & National Cancer Institute (NCI), Clinical
  Sequencing Exploratory Research (CSER) Consortium and Clinical Sequencing Evidence-Generating Consortium (CSER2) (currently Affiliate Member, CSER2 Consortium) (2011-present)
• Member, Institute of Medicine (IOM), National Academies, Committee
  for Review of the Appropriate Use of the Armed Forces Institute of
  Pathology’s Tissue Repository (2011-12)
• Editorial Board, Neuroethics (2007-present)
• McKnight Presidential Professor of Law, Medicine & Public Policy,
  University of Minnesota (2006-present)
• David Barap Brin Visiting Professor, Johns Hopkins University School
  of Medicine (2002)
• Editorial Board, Journal of Law, Medicine & Ethics (2002-present)
• Editorial Board, American Journal of Bioethics (2001-04)
• Faegre Baker Daniels Professor, University of Minnesota Law School
  (2000-present)
• Julius E. Davis Professor, University of Minnesota Law School
  (1999-2000)
• Opperman Research Scholar, University of Minnesota Law School
  (1998-99)
• Medical School Merit Award, University of Minnesota (1996)
• Jonathan J. King Lectureship, Stanford University Medical Center
  (1994)
• Fellow, Program in Ethics & the Professions, Harvard University
  (1992-93)
• Maclean Fellow, Princeton University (1988-89)
• National Endowment for the Humanities (NEH) Fellow, The Hastings
  Center (1984-85)

Professional Associations

• Member, National Academy of Medicine (formerly Institute of Medicine) (2009-present)
• Fellow, American Association for the Advancement of Science (AAAS) (2008-present)
• Fellow, The Hastings Center (1993-present)
• National Endowment for the Humanities (NEH) Fellow, The Hastings Center (1984-85)
• Member, American Law Institute (ALI) (2014-present)
• Member, National Science Advisory Board for Biosecurity (NSABB) (2011-present)

Research Publications

Selected Recent Publications:

• S Lim, DA DeBruin, JP Leider, N Sederstrom, R Lynfield, JV Baker, S Kline, S Kesler, S Rizza, J Wu, RR Sharp, SM Wolf. Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic. Mayo Clin Proc 2020;95:1946-54.
• FX Shen, SM Wolf, RG Gonzalez, M Garwood. Ethical Issues Posed by Field Research Using Highly Portable and Cloud-Enabled Neuroimaging. Neuron 2020;105:771-75.
• BJ Evans, SM Wolf. A Faustian Bargain that Imperils People’s Rights to See Their Own Personal Information. Florida Law Rev 2019;71:1281-345.
• SM Wolf, BJ Evans. Return of Results and Data to Study Participants. Science 2018;362:159-60.
• SM Wolf et al. Navigating the Research-Clinical Interface in Genomic Medicine: Analysis from the CSER Consortium. Genet Med 2017;20:545-53.
• SM Wolf, N Berlinger, B Jennings. 40 Years of Work on End-of-Life Care: From Patients’ Rights to Systemic Reform. New Engl J Med 2015;372:678-82.
• SM Wolf et al. Returning a Research Participant’s Genomic Results to Relatives: Analysis & Recommendations. J Law Med Ethics 2015;43:440-63.
• SM Wolf, W Burke, BA Koenig. Mapping the Ethics of Translational Genomics: Situating Return of Results and Navigating the Research-Clinical Divide. J Law Med Ethics 2015;43:486-501.
• C Radecki Breitkopf, GM Petersen, SM Wolf, et al. Preferences Regarding Return of Genomic Results to Family Members of Research Participants, Including After Participant Death: Empirical Results from a Cancer Biobank. J Law Med Ethics 2015;43:464-75.
• SM Wolf, GJ Annas, S Elias. Patient Autonomy and Incidental Findings in Clinical Genomics. 340 Science 2013;340:1049-50.
• SM Wolf. Return of Individual Research Results and Incidental Findings: Facing the Challenges of Translational Science. Ann Rev Genomics Hum Genet 2013;14:557-77.

Bio

Administrator Info
Name: Emily Olmsted-Morales
Phone: 612-624-0999
Email: olmst111@umn.edu
Fax: 612-625-2174

Summary
Dr. Jennifer Wong practices general pulmonary medicine seeing patients in both the clinic and hospital setting along with treating patients in the medical intensive care unit. She completed additional training in interventional pulmonary medicine and spends a portion of her clinical time performing airway, pleural, and diagnostic procedures in the operating room and bronchoscopy suite along with seeing patients in an interventional pulmonary clinic. Dr. Wong has previously completed research evaluating patient preferences in regards to life sustaining treatment, which remains an area of interest. She is also actively involved in evaluating new techniques as it relates to interventional pulmonary procedures.

Research Summary

• Code status
• Novel interventional pulmonary techniques

Teaching Summary

• Resident Education

Clinical Summary

• General Pulmonary
• Interventional Pulmonary
• Critical Care

Bio

Administrator Info
Name: DHM Admin Team
Email: dhmadmin@umn.edu
Mail: 420 Delaware St SE, MMC 741, Minneapolis, MN 55455

Summary
Dr. Wyman is an Assistant Professor in the Departments of Medicine and Pediatrics at the University of Minnesota. She is a graduate of Northwestern University, the University of Minnesota Medical School, and completed residency training in both Internal Medicine and Pediatrics at the University of Minnesota. Dr. Wyman currently practices hospital medicine at the University of Minnesota for adults and pediatrics as well as at Fairview Ridges Hospital in Pediatrics. In addition to clinical duties, she is the Director for Resident Ultrasound Education for the U of MN Internal Medicine Residency Programs. Her additional interests include global health, health disparities, medical education, and medical ethics. In her free time Dr. Wyman practices martial arts and spends times with her family.

Research Summary

• Medical Education
• Point of Care Ultrasound
• Global Health

Teaching Summary

• Introduction to Ultrasound
• Advanced Ultrasound Elective

Clinical Summary

• Evidence-based medicine
• Pediatric to Adult transitions of care
• Quality of Life
• Asthma
• Resident and Medical Student Education

Bio

Administrator Info
Name: Jane Hutchins-Peterson
Email: jhutchin@umn.edu
Mail: CCRB
2231 6th St SE
MMC 2812
Minneapolis, MN 55455

Summary
Study the effect of mitochondrial calcium handling on heart failure arrhythmia.

Research Summary

The relationship between mitochondrial calcium handling and heart failure arrhythmia.

Clinical Summary

Arrhythmia